Cargando…
Validation of MRC Centre MRI calf muscle fat fraction protocol as an outcome measure in CMT1A
OBJECTIVE: To translate the quantitative MRC Centre MRI protocol in Charcot-Marie-Tooth disease type 1A (CMT1A) to a second site; validate its responsiveness in an independent cohort; and test the benefit of participant stratification to increase outcome measure responsiveness. METHODS: Three health...
Autores principales: | Morrow, Jasper M., Evans, Matthew R.B., Grider, Tiffany, Sinclair, Christopher D.J., Thedens, Daniel, Shah, Sachit, Yousry, Tarek A., Hanna, Michael G., Nopoulos, Peggy, Thornton, John S., Shy, Michael E., Reilly, Mary M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161551/ https://www.ncbi.nlm.nih.gov/pubmed/30120135 http://dx.doi.org/10.1212/WNL.0000000000006214 |
Ejemplares similares
-
Stability and sensitivity of water T
(2) obtained with IDEAL‐CPMG in healthy and fat‐infiltrated skeletal muscle
por: Sinclair, Christopher D.J., et al.
Publicado: (2016) -
Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A
por: Eichinger, Katy, et al.
Publicado: (2022) -
PMP22 exon 4 deletion causes ER retention of PMP22 and a gain‐of‐function allele in CMT1E
por: Wang, David S., et al.
Publicado: (2017) -
Unfolded protein response, treatment and CMT1B
por: Bai, Yunhong, et al.
Publicado: (2013) -
Transmembrane protease serine 5: a novel Schwann cell plasma marker for CMT1A
por: Wang, Hongge, et al.
Publicado: (2019)